Amgen Inc.
Market Cap
$197.97B
P/E Ratio
25.77
EPS
$14.25
Dividend Yield
2.61%
52-Week Range
$261.43 — $391.29
Volume
704.94K
Avg Volume
2.81M
Beta
0.42
P/E (TTM)
25.77
Forward P/E
16.40
PEG Ratio
2.59
P/S (TTM)
5.42
P/B (TTM)
23.00
P/FCF
183.58
EV/EBITDA
63.76x
EV/Sales
—
ROE (TTM)
0.97%
ROA (TTM)
0.09%
ROIC
0.06%
Gross Margin
0.70%
Operating Margin
0.28%
Net Margin
0.14%
Debt/Equity
6.31
Current Ratio
1.14
EPS Growth (YoY)
+1.13%
Revenue Growth (YoY)
+0.09%
EPS Growth (3Y)
+0.17%
EPS Growth (5Y)
+0.11%
Sales Growth (3Y)
+0.12%
Sales Growth (5Y)
+0.08%
EPS Est (This Year)
$22.40
EPS Est (Next Year)
$23.33
Dividend Yield
—
Annual Dividend
$2.38
Payout Ratio
0.96%
Frequency
—
Ex-Dividend Date
2025-11-21
Cash/Share
$16.94
Hold
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $347.57(-5.4% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
539.07M
Float
537.73M
Free Float %
99.75%
RSI (14)
55.30
SMA 20
$375.80
SMA 50
$353.60
SMA 200
$314.41
ATR (14)
9.43
Volatility (Week)
0.02%
Volatility (Month)
0.02%
Pattern
—
1 Day
+2.01%
1 Week
-2.26%
1 Month
+2.49%
3 Months
+10.82%
6 Months
+32.90%
1 Year
—
YTD
+15.06%
All-Time High
$385.12
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
US
Exchange
NASDAQ
IPO Date
1983-06-17
Employees
28000
CEO
Robert A. Bradway
Index Membership
Dow Jones, S&P 500
Website
https://www.amgen.com
Amgen Inc. (AMGN) is a healthcare company in the drug manufacturers - general industry listed on the NASDAQ. With a market capitalization of $197.97B, a P/E ratio of 25.77, and a dividend yield of 2.61%, AMGN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AMGN against other stocks using dozens of fundamental and technical filters.
Amgen Inc. (AMGN) has a trailing twelve-month (TTM) P/E ratio of 25.77. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Amgen Inc. (AMGN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Amgen Inc. (AMGN) has a market capitalization of $197.97 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Hold" rating on Amgen Inc. (AMGN) with an average score of 2.80 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $347.57 implies 5.4% downside from the current price.
Amgen Inc. (AMGN) has returned +15.06% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.